Androgel Illinois Verdict
AbbVie Ordered to Pay $150 Million for False AndroGel Ads
July 24, 2017
A federal jury in Illinois has ruled that pharmaceutical manufacturer AbbVie must pay $150 million in punitive damages for advertisements that made false claims about its topical testosterone replacement therapy drug AndroGel.
In a trial brought by plaintiff Jesse Mitchell, who had alleged that his 2012 heart attack was caused by AndroGel, the jury found AbbVie not guilty of negligence, but guilty of fraudulent misrepresentation. Mitchell had argued that AbbVie had falsely promoted AndroGel to users for whom the drug was not medically appropriate.
The jury awarded no compensatory damages to Mitchell.
The decision is the first in a Multi-District Litigation (MDL) that collects thousands of lawsuits over the alleged heart attack and other health risks linked to AndroGel.
Several other cases in the MDL have yet to be tried.
If you think your heart attack might have been caused by AndroGel or other topical testosterone replacement therapy medications, you may be entitled to significant financial compensation. Contact the expert attorneys at TheLawFirm.com right away.
Androgel side effects lawsuit
Androgel insufficient labelling lawsuit
Does Androgel do more harm than good?
Androgel misleading ads lawsuit
Androgel Illinois verdict
Doctor testifies about Androgel and heart attacks risks
Abbvie claims FDA never requested study of Androgel and risk of heart attacks
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!